• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险移植项目参与条件实施前后时期的患者选择与数量

Patient selection and volume in the era surrounding implementation of Medicare conditions of participation for transplant programs.

作者信息

White Sarah L, Zinsser Dawn M, Paul Matthew, Levine Gregory N, Shearon Tempie, Ashby Valarie B, Magee John C, Li Yi, Leichtman Alan B

机构信息

Department of Internal Medicine, Division of Nephrology, Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, MI; The George Institute for International Health, University of Sydney, Camperdown, NSW.

出版信息

Health Serv Res. 2015 Apr;50(2):330-50. doi: 10.1111/1475-6773.12188. Epub 2014 May 19.

DOI:10.1111/1475-6773.12188
PMID:24838079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4369212/
Abstract

OBJECTIVE

To evaluate evidence of practice changes affecting kidney transplant program volumes, and donor, recipient and candidate selection in the era surrounding the introduction of Centers for Medicare and Medicaid Services (CMS) conditions of participation (CoPs) for organ transplant programs.

DATA

Scientific Registry of Transplant Recipients; CMS ESRD and Medicare claims databases.

DESIGN

Retrospective analysis of national registry data.

METHODS

A Cox proportional hazards model of 1-year graft survival was used to derive risks associated with deceased-donor kidney transplants performed from 2001 to 2010.

FINDINGS

Among programs with ongoing noncompliance with the CoPs, kidney transplant volumes declined by 38 percent (n = 766) from 2006 to 2011, including a 55 percent drop in expanded criteria donor transplants. Volume increased by 6 percent (n = 638) among programs remaining in compliance. Aggregate risk of 1-year graft failure increased over time due to increasing recipient age and obesity, and longer ESRD duration.

CONCLUSIONS

Although trends in aggregate risk of 1-year kidney graft loss do not indicate that the introduction of the CoPs has systematically reduced opportunities for marginal candidates or that there has been a systematic shift away from utilization of higher risk deceased donor kidneys, total volume and expanded criteria donor utilization decreased overall among programs with ongoing noncompliance.

摘要

目的

评估在医疗保险和医疗补助服务中心(CMS)出台器官移植项目参与条件(CoP)前后,影响肾移植项目数量以及供体、受体和候选者选择的实践变化证据。

数据

移植受者科学注册系统;CMS终末期肾病和医疗保险理赔数据库。

设计

对国家注册数据进行回顾性分析。

方法

采用Cox比例风险模型分析2001年至2010年期间进行的 deceased - donor 肾移植1年移植物存活相关风险。

结果

在持续不符合CoP的项目中,2006年至2011年肾移植数量下降了38%(n = 766),其中扩展标准供体移植下降了55%。在持续符合规定的项目中,数量增加了6%(n = 638)。由于受者年龄增长、肥胖以及终末期肾病病程延长,1年移植物失败的总体风险随时间增加。

结论

尽管1年肾移植丢失的总体风险趋势并不表明CoP的引入系统性地减少了边缘候选者的机会,也不表明存在从使用高风险 deceased 供体肾脏的系统性转变,但在持续不符合规定的项目中,总体数量和扩展标准供体的利用率总体下降。

相似文献

1
Patient selection and volume in the era surrounding implementation of Medicare conditions of participation for transplant programs.医疗保险移植项目参与条件实施前后时期的患者选择与数量
Health Serv Res. 2015 Apr;50(2):330-50. doi: 10.1111/1475-6773.12188. Epub 2014 May 19.
2
Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival.死亡供体急性肾损伤与受者移植物存活的关系。
JAMA Netw Open. 2020 Jan 3;3(1):e1918634. doi: 10.1001/jamanetworkopen.2019.18634.
3
Kidney offer acceptance at programs undergoing a Systems Improvement Agreement.接受肾脏捐献的项目正在进行系统改进协议。
Am J Transplant. 2018 Sep;18(9):2182-2188. doi: 10.1111/ajt.14907. Epub 2018 Jun 4.
4
The OPTN/UNOS Renal Transplant Registry.器官获取与移植网络/美国器官共享联合网络肾脏移植登记处
Clin Transpl. 2005:1-16.
5
Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survival.心血管合并症调整对 SRTR 风险调整 Cox 比例风险模型中移植物存活率的影响。
Transplantation. 2014 Mar 27;97(6):686-93. doi: 10.1097/01.TP.0000437181.95701.32.
6
Transplant center regulations--a mixed blessing? An ASTS Council viewpoint.移植中心规定——是福是祸?美国移植外科学会理事会观点
Am J Transplant. 2008 Dec;8(12):2496-502. doi: 10.1111/j.1600-6143.2008.02434.x.
7
Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes.移植中心容量与 3 年临床结果的相关性。
Am J Kidney Dis. 2019 Oct;74(4):441-451. doi: 10.1053/j.ajkd.2019.02.019. Epub 2019 May 7.
8
The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis.肾移植实践不断变化的金融格局:一项全国队列分析。
Am J Transplant. 2017 Feb;17(2):377-389. doi: 10.1111/ajt.14018. Epub 2016 Oct 4.
9
The UNOS Scientific Renal Transplant Registry.美国器官共享联合网络科学肾脏移植登记处。
Clin Transpl. 1996:1-14.
10
Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.成人肾移植后淋巴组织增生性疾病:流行病学及登记报告与基于理赔诊断的比较。
Am J Kidney Dis. 2011 Dec;58(6):971-80. doi: 10.1053/j.ajkd.2011.07.015. Epub 2011 Sep 17.

引用本文的文献

1
Patient selection in the presence of regulatory oversight based on healthcare report cards of providers: the case of organ transplantation.在监管监督下基于医疗保健提供者报告卡的患者选择:器官移植的案例。
Health Care Manag Sci. 2021 Mar;24(1):160-184. doi: 10.1007/s10729-020-09530-4. Epub 2021 Jan 8.
2
Transplant community perceptions of the benefits and drawbacks of alternative quality metrics for regulation.移植社区对替代质量指标在监管方面的优缺点的看法。
Clin Transplant. 2019 Apr;33(4):e13500. doi: 10.1111/ctr.13500. Epub 2019 Mar 6.
3
Quality-based ratings in Medicare and trends in kidney transplantation.医疗保险中的质量评级与肾脏移植的趋势。
Health Serv Res. 2019 Feb;54(1):106-116. doi: 10.1111/1475-6773.13098. Epub 2018 Dec 5.
4
Reported effects of the Scientific Registry of Transplant Recipients 5-tier rating system on US transplant centers: results of a national survey.报告的器官移植受者科学注册系统 5 级评分系统对美国移植中心的影响:全国调查结果。
Transpl Int. 2018 Oct;31(10):1135-1143. doi: 10.1111/tri.13282. Epub 2018 Jun 10.
5
Kidney offer acceptance at programs undergoing a Systems Improvement Agreement.接受肾脏捐献的项目正在进行系统改进协议。
Am J Transplant. 2018 Sep;18(9):2182-2188. doi: 10.1111/ajt.14907. Epub 2018 Jun 4.
6
Measuring transplant center performance: The goals are not controversial but the methods and consequences can be.衡量移植中心的表现:目标并无争议,但方法和结果可能存在争议。
Curr Transplant Rep. 2017 Mar;4(1):52-58. doi: 10.1007/s40472-017-0138-9. Epub 2017 Feb 8.
7
Building an Ideal Quality Metric for ESRD Health Care Delivery.构建终末期肾病医疗服务的理想质量指标
Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1351-1356. doi: 10.2215/CJN.01020117. Epub 2017 May 17.
8
Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys.高KDPI肾脏早期移植对老年患者的生存益处。
Transplantation. 2017 Apr;101(4):867-872. doi: 10.1097/TP.0000000000001405.
9
Considering potential benefits and consequences of hospital report cards: what are the next steps?考虑医院报告卡的潜在益处与后果:接下来的步骤是什么?
Health Serv Res. 2015 Apr;50(2):321-9. doi: 10.1111/1475-6773.12280.

本文引用的文献

1
Regulatory oversight in transplantation: are the patients really better off?移植中的监管监督:患者真的受益了吗?
Curr Opin Organ Transplant. 2013 Apr;18(2):203-9. doi: 10.1097/MOT.0b013e32835f3fb4.
2
The association of center performance evaluations and kidney transplant volume in the United States.美国中心绩效评估与肾移植量的相关性。
Am J Transplant. 2013 Jan;13(1):67-75. doi: 10.1111/j.1600-6143.2012.04345.x.
3
Balancing accountable care with risk aversion: transplantation as a model.平衡责任医疗与风险规避:以移植为例
Am J Transplant. 2013 Jan;13(1):7-8. doi: 10.1111/j.1600-6143.2012.04346.x.
4
The association of community health indicators with outcomes for kidney transplant recipients in the United States.美国社区健康指标与肾移植受者结局的关联。
Arch Surg. 2012 Jun;147(6):520-6. doi: 10.1001/archsurg.2011.2220.
5
Pulsatile perfusion preservation for expanded-criteria donors kidneys: Impact on delayed graft function rate.扩大标准供体肾脏的搏动灌注保存:对移植肾功能延迟恢复率的影响。
Int J Artif Organs. 2011 Jun;34(6):513-8. doi: 10.5301/IJAO.2011.8458.
6
Transplanting kidneys without points for HLA-B matching: consequences of the policy change.无 HLA-B 配型分数的肾脏移植:政策改变的后果。
Am J Transplant. 2011 Aug;11(8):1712-8. doi: 10.1111/j.1600-6143.2011.03606.x. Epub 2011 Jun 14.
7
Increasing organ donation and transplantation: the U.S. experience over the past decade.提高器官捐赠和移植数量:美国过去十年的经验。
Transpl Int. 2011 Apr;24(4):324-32. doi: 10.1111/j.1432-2277.2010.01201.x. Epub 2011 Jan 5.
8
Significant alterations in reported clinical practice associated with increased oversight of organ transplant center performance.与加强对器官移植中心绩效的监督相关的已报告临床实践中的重大改变。
Prog Transplant. 2010 Sep;20(3):279-87. doi: 10.1177/152692481002000313.
9
CMS oversight, OPOs and transplant centers and the law of unintended consequences.CMS 监管、OPO 与移植中心,以及意料之外的法律后果。
Clin Transplant. 2009 Nov-Dec;23(6):778-83. doi: 10.1111/j.1399-0012.2009.01157.x.
10
DonorNet and the potential effects on organ utilization.供体网及其对器官利用的潜在影响。
Am J Transplant. 2010 Apr;10(4 Pt 2):1081-9. doi: 10.1111/j.1600-6143.2010.03036.x.